Chemical Abstracts Service

Chemical Abstracts Service
source
Name	Chemical Abstracts Service
Type	Division of a nonprofit scientific organization
Founded	1907
Headquarters	Columbus, Ohio
Parent	American Chemical Society

Chemical Abstracts Service Chemical Abstracts Service is a division of the American Chemical Society providing comprehensive chemical information and substance identification services to researchers, corporations, and agencies. Founded in 1907 during the rise of organized scientific indexing, CAS compiles bibliographic and substance data used by libraries, pharmaceutical companies, and regulatory bodies. Its products and identifiers underpin workflows at institutions such as Pfizer, Bayer, Eli Lilly and Company, GlaxoSmithKline, and governmental agencies including the U.S. Food and Drug Administration, European Medicines Agency, and Environmental Protection Agency.

History

CAS originated within the American Chemical Society in the early 20th century as an editorial response to increasing chemical literature produced by institutions like Massachusetts Institute of Technology and University of Cambridge. Early contributors included chemists affiliated with Harvard University, Yale University, and University of Chicago who cataloged abstracts from journals such as Journal of the American Chemical Society and Berichte der deutschen chemischen Gesellschaft. During World War II, CAS expanded operations alongside wartime research at DuPont, I.G. Farben, and national laboratories like Los Alamos National Laboratory and Oak Ridge National Laboratory. Postwar growth accelerated with collaborations involving National Institutes of Health, National Science Foundation, and industrial research at General Electric and Siemens. The move to Columbus paralleled expansions seen at facilities such as Bell Laboratories and Rutherford Appleton Laboratory, and the development of computerized indexing followed advances by institutions like IBM and Digital Equipment Corporation.

Organization and Services

CAS functions as a specialized division within the American Chemical Society and interfaces with academic libraries such as the Library of Congress, British Library, and Bibliothèque nationale de France. It maintains editorial standards comparable to those at Nature Publishing Group and Springer Nature and provides services to corporations including Merck & Co., Novartis, Roche, and Sanofi. CAS operates proprietary indexing and abstracting workflows similar to those used by Clarivate Analytics and Elsevier and partners with licensors, research institutions, and patent offices such as the United States Patent and Trademark Office, European Patent Office, and World Intellectual Property Organization to support patent searching and chemical disclosure review.

CAS Registry and Numbering System

The CAS Registry assigns unique numerical identifiers to substances used globally by researchers at Stanford University, MIT, Caltech, and industry labs at BASF, 3M, and Honeywell. CAS Registry Numbers are cited in regulatory filings with agencies like the FDA, EMA, and Food and Agriculture Organization and are used in standards by organizations such as ISO and ASTM International. The numbering system supports cross-referencing in patent prosecution before the United States Patent and Trademark Office and European Patent Office and appears in safety data sheets compliant with Occupational Safety and Health Administration and Globally Harmonized System of Classification and Labelling of Chemicals implementations.

Products and Databases

CAS delivers products including literature abstracts, substance databases, and analytical tools used by researchers at Johns Hopkins University, Imperial College London, and University of Tokyo. Major offerings parallel services like Scopus and Web of Science and include databases accessed by corporate R&D teams at Toyota Research Institute, Honda, and Boeing. CAS platforms are utilized in drug discovery pipelines at AstraZeneca, Johnson & Johnson, and AbbVie and support cheminformatics capabilities comparable to software from Schrödinger, BIOVIA, and ChemAxon.

Role in Research and Industry

CAS data underpin literature reviews and patent landscaping performed by teams at MIT, Oxford University, ETH Zurich, and national research centers such as Lawrence Berkeley National Laboratory. Pharmaceutical development stages at Roche, Pfizer, and Gilead Sciences rely on CAS identifiers for compound registration, while materials science projects at Samsung, LG Chem, and Dow Chemical Company use CAS resources for formulation and safety assessment. Regulatory submissions to FDA, EMA, and Health Canada commonly reference CAS Registry Numbers, and collaborations with standards bodies like ASTM International and ISO embed CAS terms into technical specifications.

Criticisms and Legal Issues

CAS has faced scrutiny over subscription pricing and access limitations similar to controversies involving Elsevier and Clarivate Analytics, prompting debate among institutions such as Harvard University, University of California, and the Max Planck Society. Legal disputes and policy discussions have involved intellectual property considerations resonant with cases before the United States Supreme Court and regulatory reviews by agencies like the Federal Trade Commission. Open access advocates and organizations including SPARC and Creative Commons have criticized proprietary control of identifiers, while patent applicants before the European Patent Office and United States Patent and Trademark Office debate reliance on commercial registries versus public-domain alternatives developed by consortia involving National Institutes of Health and World Health Organization.

Category:Chemical information